Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading up 49 points (0.3%) at 16,411 as of Monday, April 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,415 issues advancing vs. 1,576 declining with 152 unchanged.

The Health Services industry currently sits down 1.3% versus the S&P 500, which is unchanged. A company within the industry that increased today was

Smith & Nephew

(

SNN

), up 0.8%. On the negative front, top decliners within the industry include

Haemonetics

(

HAE

), down 8.7%,

Icon

(

ICLR

), down 7.0%,

Parexel International

(

PRXL

), down 6.4%,

Charles River Laboratories International In

(

CRL

), down 5.2% and

Covance

(

CVD

), down 3.3%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

CareFusion

(

CFN

) is one of the companies pushing the Health Services industry higher today. As of noon trading, CareFusion is up $0.26 (0.7%) to $38.42 on heavy volume. Thus far, 1.2 million shares of CareFusion exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $38.19-$38.72 after having opened the day at $38.30 as compared to the previous trading day's close of $38.16.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. CareFusion has a market cap of $8.0 billion and is part of the health care sector. The company has a P/E ratio of 24.5, above the S&P 500 P/E ratio of 17.7. Shares are down 4.2% year-to-date as of the close of trading on Friday. Currently there are 5 analysts who rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

CareFusion

as a

buy

TheStreet Recommends

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

CareFusion Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading,

Intuitive Surgical

(

ISRG

) is up $1.86 (0.5%) to $368.23 on average volume. Thus far, 284,036 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 604,200 shares. The stock has ranged in price between $366.67-$371.89 after having opened the day at $368.90 as compared to the previous trading day's close of $366.37.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $14.2 billion and is part of the health care sector. The company has a P/E ratio of 25.6, above the S&P 500 P/E ratio of 17.7. Shares are down 4.6% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Intuitive Surgical a buy, 5 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Intuitive Surgical

as a

buy

. Among the primary strengths of the company is its expanding profit margins over time. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Intuitive Surgical Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

Baxter International

(

BAX

) is up $0.50 (0.7%) to $72.82 on light volume. Thus far, 1.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.6 million shares. The stock has ranged in price between $72.24-$72.99 after having opened the day at $72.60 as compared to the previous trading day's close of $72.32.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $39.1 billion and is part of the health care sector. The company has a P/E ratio of 18.4, above the S&P 500 P/E ratio of 17.7. Shares are up 4.0% year-to-date as of the close of trading on Friday. Currently there are 4 analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Baxter International Ratings Report

now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null